DUBLIN--(BUSINESS WIRE)--

Dublin - Research and Markets (http://www.researchandmarkets.com/research/aaa990c9/research_report_on) has announced the addition of the "Research Report on Chinese Monoclonal Antibody Industry, 2012" report to their offering.

Antibody medicine is generally obtained from monoclonal antibody through genetic engineering, possessing the advantages of strong targeting and few drug side effects. At the present time, it is mainly used for the cure of tumor and immune system diseases and has good application prospects in clinical treatment. From the point of the global market, antibody medicine accounts for over 40% of the entire biotechnology medicine. With constant growth of the market share, antibody medicine has become the most important part of the biotechnology medicine, and monoclonal antibody medicine is the best-selling product in the antibody medicine. In 2010, in the 10 world's best-selling drugs, monoclonal antibody medicine took up 5, and the market sales revenue of each single product all exceeded USD 5 billion.

More following information can be acquired through this report:

- Development Course of Chinese Monoclonal Antibody Market

- Competition in Chinese Monoclonal Antibody Market

- Research and Development of Chinese Monoclonal Antibody Market

- Major Monoclonal Antibody Production Enterprises in Chinese Market

- Hot Products of Chinese Monoclonal Antibody Market

- Prediction on Chinese Monoclonal Antibody Market

Continued here:
Research and Markets: Research Report on Chinese Monoclonal Antibody Industry, 2012

Comments are closed.